Hypertension as a surrogate marker for the activity of anti-VEGF agents.
Mir
O
O
Ropert
S
S
Alexandre
J
J
Goldwasser
F
F
D020533:Angiogenesis Inhibitors / Q000009:adverse effects*; D001794:Blood Pressure / Q000187:drug effects; D006801:Humans; D006973:Hypertension / Q000139:chemically induced* / Q000503:physiopathology; D009369:Neoplasms / Q000098:blood supply / Q000188:drug therapy*; D016896:Treatment Outcome; D042461:Vascular Endothelial Growth Factor A / Q000037:antagonists & inhibitors*
D020533:Angiogenesis Inhibitors; C467484:VEGFA protein, human; D042461:Vascular Endothelial Growth Factor A